Oxxius announces the strategic acquisition of US company 89 North

Oxxius, a recognized leader in the design, development, and manufacture of high-performance lasers and combiners, announced the acquisition of 89 North, a U.S.-based expert in the development of advanced laser-based lighting and imaging systems.

A transformative acquisition that supports an ambitious growth strategy
This transaction marks an important step in Oxxius' international growth strategy. It should increase global revenue starting next year, enabling the company to reach a new scale that will enhance its visibility. It will also strengthen competitiveness through the exchange of expertise between the teams of both companies.

By integrating 89 North's technology and expertise, Oxxius will expand its offering, particularly its portfolio of laser combiners, to better meet the needs of customers in several markets, with a particular focus on life sciences.

Geographic synergies: strengthening global presence
This acquisition will enable tangible geographic synergies to be achieved:
- Oxxius will strengthen its operational and commercial presence in the United States in order to better support its customers in North America, one of the most dynamic markets in the sector.
- 89 North will leverage Oxxius' well-established presence and network to accelerate its growth, particularly in the European and Asian markets.

Technological synergies serving all players in the life sciences sector
The integration of 89 North's high-power diode laser illuminators will significantly strengthen Oxxius' competitiveness, particularly in the microscopy markets. Oxxius will thus be able to meet the needs of allplayers in the sector, from standard applications to the most demanding configurations.